uniQure N.V. (NASDAQ: QURE) Stock Information | RedChip

uniQure N.V. (NASDAQ: QURE)


$6.0100
+0.2300 ( +2.39% ) 233.7K

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Market Data


Open


$6.0100

Previous close


$5.7800

Volume


233.7K

Market cap


$301.72M

Day range


$5.7800 - $6.2350

52 week range


$3.7300 - $11.3500

SEC Filings


Form Type Description Pages Date
8-k 8K-related 13 Nov 17, 2023
10-q Quarterly Reports 64 Nov 07, 2023
8-k 8K-related 14 Nov 07, 2023

Latest News